文献速递肝胆胰外科围术期管理与 ERAS

基于NSQIP胰腺示范项目构建改良胰瘘风险评分用于胰十二指肠切除术前风险分层

Using the NSQIP Pancreatic Demonstration Project to Derive a Modified Fistula Risk Score for Preoperative Risk Stratification in Patients Undergoing Pancreaticoduodenectomy.
PubMed 文献 · J Am Coll Surg · 2017-04-10

该研究利用2012年NSQIP胰腺示范项目14个月内1731例胰十二指肠切除术数据,以70%队列开发、30%内部验证,并外部队列验证,构建了基于性别、BMI、术前总胆红素、胰管直径和腺体质地的10分改良胰瘘风险评分。评分0-2、3-6、7-8、9-10分对应临床相关术后胰瘘(CR-POPF)发生率在测试组为0%、6.7%、16.4%、33.7%,内部验证为0%、6.3%、13.5%、31.0%,外部验证为2.9%、10.2%、16.4%、25.8%。

要点

  • 改良胰瘘风险评分仅用术前及易得术中因素,可在切除前评估CR-POPF风险。
  • 评分0-2分为极低危,9-10分为高危,对应CR-POPF率最高达33.7%。
  • 该评分可用于术前咨询、比较外科医生表现与全国标准。

核心结论

  • 改良胰瘘风险评分可利用术前和易确定的术中因素估计CR-POPF风险,并支持与全国标准比较、改善围术期咨询及评估干预措施。

研究设计与样本

  • 基于2012年NSQIP胰腺示范项目14个月内1731例胰十二指肠切除术,随机70%队列开发模型、30%内部验证,并利用2014年PDP进行外部验证。

主要发现

  • 识别出性别、BMI、术前总胆红素、胰管直径和腺体质地5个显著预测因子,按比值比赋分构建10分模型。
  • 测试组评分0-2、3-6、7-8、9-10分对应CR-POPF率为0%、6.7%、16.4%、33.7%。
  • 内部验证对应CR-POPF率为0%、6.3%、13.5%、31.0%。
  • 外部验证对应CR-POPF率为2.9%、10.2%、16.4%、25.8%。

关键数值与推荐

  • 风险评分0-2分为极低危,3-6分为低危,7-8分为中危,9-10分为高危。
  • 单变量分析中p<0.1的变量纳入多变量建模。

临床怎么用

  • 术前使用改良评分对胰十二指肠切除术患者进行CR-POPF风险分层,辅助围术期咨询和干预决策。
  • 可利用评分比较个体外科医生CR-POPF表现与全国标准。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The Fistula Risk Score (FRS) is a clinical tool developed from single-institutional data using primarily intraoperative factors to characterize the risk of clinically relevant pancreatic fistula (CR-POPF) after pancreaticoduodenectomy. We developed a modified FRS based on objective, nationally accrued data that is more readily determined before resection. STUDY DESIGN: The 2012 NSQIP Pancreatic Demonstration Project (PDP) was used to identify 1,731 pancreaticoduodenectomy resections over 14 months (2011 to 2012). A randomly generated 70% cohort was used for model development, and the remaining 30% for internal validation. Univariate analysis was used to identify predictors of CR-POPF. Variables with a value of p < 0.1 were included in multivariable modeling. RESULTS: Five significant predictors of CR-POPF were identified and assigned points based on odds ratios: sex, BMI, preoperative total bilirubin, pancreatic ductal diameter, and gland texture. The 10-point model was further applied to the 2014 PDP for external validation. In the testing group, risk scores of 0 to 2 (negligible risk), 3 to 6 (low risk), 7 to 8 (intermediate risk), and 9 to 10 (high risk) were associated with CR-POPF rates of 0%, 6.7%, 16.4%, and 33.7%, respectively. Similar values were seen using the internal validation cohort: 0%, 6.3%, 13.5%, and 31.0%, respectively. The external validation values were 2.9%, 10.2%, 16.4%, and 25.8%, respectively. CONCLUSIONS: This modified FRS allows for estimation of CR-POPF risk using preoperative and easily determined intraoperative factors, and will allow comparison of performance data for individual surgeons to national norms, improved perioperative counseling, and potential for scrutinizing and/or implementing interventions designed to decrease CR-POPF rates.

来源:J Am Coll Surg,查看原文。版权归原作者所有。

引用

  1. Kantor O, Talamonti MS, Pitt HA, et al. Using the NSQIP Pancreatic Demonstration Project to Derive a Modified Fistula Risk Score for Preoperative Risk Stratification in Patients Undergoing Pancreaticoduodenectomy. J Am Coll Surg. 2017. PMID: 28408176. doi:10.1016/j.jamcollsurg.2017.01.054

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。